Skip to content Skip to footer
Adalimumab: Benefits, Reviews, Info, Side Effects!
Rx Details
Adalimumab
Humira, Exemptia, Amgevita, Hulio
Adalimumab
Prescription
Biologic
Drugs
Prescription Only
reduces inflammation, treats rheumatoid arthritis, treats psoriatic arthritis, treats ankylosing spondylitis, treats Crohn’s disease, treats ulcerative colitis, treats plaque psoriasis, treats hidradenitis suppurativa, improves quality of life, slows disease progression
Abdominal Pain, Allergic Reactions, Back Pain, Blood Disorders, Demyelinating Disease, Dizziness, Fatigue, Headache, Heart Failure, Hypertension, Increased Liver Enzymes, Increased Risk Of Infections, Injection Site Reactions, Liver Problems, Lupus-Like Syndrome, Nausea, Rash, Sinusitis, Upper Respiratory Infections, Urinary Tract Infections
Adalimumab is a medication used to treat various autoimmune conditions, and its dosage can vary depending on the specific condition being treated. Here are some common dosages for adalimumab: 1. **Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis:** – The typical starting dose is 40 mg administered subcutaneously every other week. Some patients may benefit from 40 mg every week. 2. **Crohn’s Disease and Ulcerative Colitis:** – Initial dose: 160 mg on Day 1 (can be given as four 40 mg injections in one day or as two 40 mg injections per day over two consecutive days). – Second dose: 80 mg two weeks later (Day 15). – Maintenance dose: 40 mg every other week starting on Day 29. 3. **Plaque Psoriasis:** – Initial dose: 80 mg, followed by 40 mg every other week starting one week after the initial dose. 4. **Hidradenitis Suppurativa:** – Initial dose: 160 mg on Day 1, followed by 80 mg two weeks later (Day 15). – Maintenance dose: 40 mg every week starting on Day 29. These are general guidelines, and the exact dosage and frequency should be determined by a healthcare provider based on the patient’s specific condition and response to treatment. Always consult a healthcare professional for medical advice and before starting or adjusting any medication.
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, juvenile idiopathic arthritis, uveitis
Adalimumab has a generally favorable safety profile.
No Interactions Reported
$1,000 – $2,000
$5690

A Synopsis of

Adalimumab

Adalimumab, also known by its brand name Humira, is a medication that belongs to a class of drugs called tumor necrosis factor (TNF) blockers. It is commonly used to treat a variety of inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and plaque psoriasis.

Adalimumab works by targeting and blocking TNF, a protein in the body that plays a key role in the inflammatory response. By inhibiting TNF, adalimumab helps to reduce inflammation and alleviate symptoms such as joint pain, swelling, and stiffness.

It is important to note that adalimumab is a prescription medication and should only be taken under the guidance of a healthcare provider. Your doctor will determine the appropriate dosage and frequency of administration based on your specific condition and medical history.

Like all medications, adalimumab can cause side effects. Common side effects may include injection site reactions, headache, and upper respiratory infections. More serious side effects, such as infections or allergic reactions, are less common but can occur. It is important to report any unusual symptoms or side effects to your healthcare provider promptly.

Overall, adalimumab has been shown to be an effective treatment for many patients with inflammatory conditions. It can help improve quality of life and reduce disease activity. If you have been prescribed adalimumab, be sure to follow your doctor’s instructions carefully and communicate any concerns or questions you may have. Your healthcare provider is there to support you and ensure that you are receiving the best possible care.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN